You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明生物股東折讓約6.8%減持1.08億股,套現逾百億港元
uSMART盈立智投 04-27 08:12

uSMART盈立智投4月27日消息,週二港股盤前,藥明生物發佈《內幕消息》公告:

公司董事會獲本公司其中一名主要股東WuXi Biologics Holdings Limited知會,其已與摩根士丹利國際股份有限公司(配售代理)訂立大宗交易協議,據此,配售代理已同意以每股107港元的價格向獨立於本公司且與本公司概無關連的各方配售由Biologics Holdings持有的本公司1.08億股現有股份份(相當於截至本公告日期本公司已發行股本總額約2.56%)。

假設配售將按預期完成,(i)Biologics Holdings持有的本公司股權將由本公司已發行股本總額約20.00%減少至約17.44%;且(ii)Biologics Holdings將繼續爲本公司主要股東。

配售價(107港元)較每股最新收盤價(114.8港元)折讓約6.8%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account